Our Chairman and CEO Bob Proulx was a recent guest at the Fear and Greed podcast, discussing our pursuit of better, more precise imaging solutions to detect cancers.
Bob discussed with host Sean Aylmer, Imagion Bio’s nanoparticle technology, our goal of preventing unnecessary procedures, and our advancements with the Phase I clinical trial.
Imagion Biosystems is a biotech company aiming to make a difference in the lives of cancer patients, with groundbreaking imaging techniques being trialed in Australian hospitals.
CEO Bob Proulx joins Sean Aylmer from San Diego to talk about Imagion’s work, and why they chose to list on the ASX.
You can listen to the full episode HERE.